N-Larg Capsules: Label does not meet Health Canada requirements
Last updated
Summary
Product
N-Larg Capsules
Issue
Health products - Labelling
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
N-Larg |
N-Larg Capsules |
NPN 80040071 |
Capsule |
3-Pyridinecarboxamide 30.0 mg, Avena sativa 25.0 mg, Boron 230.0 mcg, Capsicum annuum 30.0 mg, Cola acuminata 40.0 mg, Cucurbita pepo 25.0 mg, Eleutherococcus senticosus 20.0 mg, L-Arginine 300.0 mg, Lepidium meyenii 500.0 mg, Panax ginseng 20.0 mg, Panax quinquefolius 20.0 mg, Smilax officinalis 20.0 mg, Tribulus terrestris 50.0 mg, Urtica dioica 25.0 mg, Zinc 15.0 mg, Zingiber officinale 30.0 mg |
210013 |
Issue
Label does not meet Health Canada requirements
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
Hanan Enterprise
406 1/2 George St, Peterborough
Ontario K9H 3R5
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-64199
Get notified
Receive notifications for new and updated recalls and alerts by category.